Why This Matters
This roundup captures how AI's real-world consequences are now landing on regulators, courts, and national security desks all at once — from lawsuits blaming OpenAI for failing to flag a shooter, to xAI losing a challenge against Minnesota's nudification ban, to federal scrutiny of Tesla's self-certified Cybercab. It also shows the upside: an AI-designed drug reportedly cut patients' biological age in a trial, and Europe finally has a commercial orbital rocket. For consumers, the common thread is that data, models, and machines built fast are increasingly being tested against the law.
Key Takeaways
- AI liability is moving to the courtroom: 30 lawsuits argue OpenAI should have warned police before the Tumbler Ridge shooting, and xAI failed to block Minnesota's ban on nonconsensual sexual deepfakes.
- Commercial data brokers are now a security threat — the US military disabled ad trackers after location data was reportedly used to target troops.
- Beyond the risks: Insilico Medicine's AI-designed rentosertib cut patients' biological age by up to six years in a trial, and Isar Aerospace's Spectrum became the first rocket to reach orbit from mainland Europe.
2 The US military has disabled ad trackers due to Middle East targeting fears
Commercial location data has reportedly been used to target troops. (Reuters $)
+ It can be sold by data brokers and used to track personnel. (Gizmodo)
+ The military is increasing restrictions on phone use overall. (Guardian)
3 A company claims its AI-designed drug can reverse aging markers
Patients’ average biological age fell by as much as six years in a clinical trial. (NYT $)
+ Insilico Medicine developed the drug, called rentosertib. (Bloomberg $)
+ Who gets the credit for AI-designed drugs? (MIT Technology Review)
4 Elon Musk’s xAI has lost its bid to block an AI-nudification ban
... continue reading
GoKawiil